Agency Forms Undergoing Paperwork Reduction Act Review, 24152-24153 [2019-10835]
Download as PDF
<![CDATA[
24152
Federal Register / Vol. 84, No. 101 / Friday, May 24, 2019 / Notices
Public Health Practice, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop D–44,
Atlanta, Georgia 30329, Telephone:
(404) 639–7450; Fax: (404) 471–8772;
Email: OPHPR.BSC.Questions@cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–10871 Filed 5–23–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP, STAC); Notice of
Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of Charter Renewal.
AGENCY:
This gives notice that under
Public Law 111–347 (the James Zadroga
9/11 Health and Compensation Act of
2010), as amended by Public Law 114–
113, and the Federal Advisory
Committee Act (Pub. L. 92–463) of
October 6, 1972, the World Trade Center
Health Program Scientific/Technical
Advisory Committee, the Centers for
Disease Control and Prevention,
Department of Health and Human
Services, has been renewed for a 2-year
period through May 12, 2021.
FOR FURTHER INFORMATION CONTACT:
Tania Carreo´n-Valencia, Ph.D.,
Designated Federal Officer, WTCHP
STAC, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
Department of Health and Human
Services, 1600 Clifton Road NE, MS: R–
12, Atlanta, GA 30329; telephone (513)
841–4515; email TCarreonValencia@
cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
khammond on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:10 May 23, 2019
Jkt 247001
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–10873 Filed 5–23–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Agency Forms Undergoing Paperwork
Reduction Act Review
Proposed Project
National Syndromic Surveillance
Program (OMB Control No. 0920–0824,
Exp. 5/31/2019)—Revision—Center for
Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled National
Syndromic Surveillance Program—
Revision to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on March 20,
2019 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
Background and Brief Description
Syndromic surveillance uses
syndromic data and statistical tools to
detect, monitor, and characterize
unusual activity for further public
health investigation or response.
Syndromic data include electronic
extracts of electronic health records
(EHRs) from patient encounter data from
emergency departments, urgent care,
ambulatory care, and inpatient
healthcare settings, as well as pharmacy
and laboratory data. Though these data
are being captured for different
purposes, they are monitored in near
real-time as potential indicators of an
event, a disease, or an outbreak of
public health significance. On the
national level, these data are used to
improve nationwide situational
awareness and enhance responsiveness
to hazardous events and disease
outbreaks to protect America’s health,
safety, and security.
The BioSense Program was created by
congressional mandate as part of the
Public Health Security and Bioterrorism
Preparedness and Response Act of 2002
and was launched by the CDC in 2003.
The BioSense Program has since been
expanded into the National Syndromic
Surveillance Program (NSSP) which
promotes and advances development of
a syndromic surveillance system for the
timely exchange of syndromic data.
CDC requests a three-year approval for
a Revision for NSSP (OMB Control No.
0920–0824, Expiration Date 5/31/2019).
This Revision includes a new request
for approval to receive onboarding data
from state, local and territorial public
health departments about healthcare
facilities in their jurisdiction.
NSSP features the BioSense Platform
and a collaborative Community of
Practice. The BioSense Platform is a
secure integrated electronic health
information system that CDC provides,
primarily for use by state, local and
Centers for Disease Control and
Prevention
[30Day–19–0824]
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
E:\FR\FM\24MYN1.SGM
24MYN1
24153
Federal Register / Vol. 84, No. 101 / Friday, May 24, 2019 / Notices
territorial public health departments. It
includes standardized analytic tools and
processes that enable users to rapidly
collect, evaluate, share, and store
syndromic surveillance data. NSSP
promotes a Community of Practice in
which participants collaborate to
advance the science and practice of
syndromic surveillance. Health
departments use the BioSense Platform
to receive healthcare data from facilities
in their jurisdiction, conduct syndromic
surveillance, and share the data with
other jurisdictions and CDC.
The BioSense Platform provides the
ability to analyze healthcare encounter
data from EHRs, as well as laboratory
data. All EHR and laboratory data reside
outside of CDC in a cloud-enabled, webbased platform that has Authorization to
Operate from CDC. The BioSense
Platform sits in the secure, private
Government Cloud which is simply
used as a storage and processing
mechanism, as opposed to on-site
servers at CDC. This environment
provides users with easily managed ondemand access to a shared pool of
configurable computing resources such
as networks, servers, software, tools,
storage, and services, with limited need
for additional IT support. Each site (i.e.,
state or local public health department)
controls its data within the cloud and is
provided with free secure data storage
space with tools for posting, receiving,
controlling and analyzing their data; an
easy-to-use data display dashboard; and
a shared environment where users can
collaborate and advance public health
surveillance practice. Each site is
responsible for creating its own data use
agreements with the facilities that are
sending the data, retains ownership of
any data it contributes to its exclusive
secure space, and can share data with
CDC or users from other sites.
NSSP has three different types of
information collection:
(1) Collection of onboarding data
about healthcare facilities needed for
state, local, and territorial public health
departments to submit EHR data to the
BioSense Platform;
(2) Collection of registration data
needed to allow users access to the
BioSense Platform tools and services;
and
(3) Collection of data sharing
permissions so that state and local
health departments can share data with
other state and local health departments
and CDC.
Healthcare data shared with CDC can
include: EHR data received by state and
local public health departments from
facilities including hospital emergency
departments and inpatient settings,
urgent care, and ambulatory care;
laboratory tests ordered and their results
from LabCorp, a national private sector
laboratory company; and EHR data from
the Department of Defense (DoD) and
the Department of Health and Human
Services (HHS) National Disaster
Medical System (NDMS) Disaster
Medical Assistance Teams (DMATs).
Respondents include state, local, and
territorial public health departments.
There are no costs to respondents other
than their time to participate. The only
burden incurred by the health
departments are for submitting
onboarding data about facilities to CDC,
submitting registration data about users
to CDC, and setting up data sharing
permissions with CDC. The estimated
annual burden is 195 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses
per
respondent
Average
burden per
response
(in hours)
Form name
State, Local, and Territorial Public Health Departments.
State, Local, and Territorial Public Health Departments.
State, Local, and Territorial Public Health Departments.
Onboarding .....................................................
10
100
10/60
Registration ....................................................
10
15
10/60
Data Sharing Permissions .............................
10
1
15/60
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–10835 Filed 5–23–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–1957]
khammond on DSKBBV9HB2PROD with NOTICES
Number of
respondents
Type of respondents
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
AGENCY:
ACTION:
Notice.
VerDate Sep<11>2014
18:10 May 23, 2019
Jkt 247001
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
SUMMARY:
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
July 23, 2019.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
E:\FR\FM\24MYN1.SGM
24MYN1
]]>Agencies
[Federal Register Volume 84, Number 101 (Friday, May 24, 2019)]
[Notices]
[Pages 24152-24153]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10835]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-19-0824]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled National Syndromic Surveillance Program--
Revision to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on March 20,
2019 to obtain comments from the public and affected agencies. CDC
received one comment related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
National Syndromic Surveillance Program (OMB Control No. 0920-0824,
Exp. 5/31/2019)--Revision--Center for Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Syndromic surveillance uses syndromic data and statistical tools to
detect, monitor, and characterize unusual activity for further public
health investigation or response. Syndromic data include electronic
extracts of electronic health records (EHRs) from patient encounter
data from emergency departments, urgent care, ambulatory care, and
inpatient healthcare settings, as well as pharmacy and laboratory data.
Though these data are being captured for different purposes, they are
monitored in near real-time as potential indicators of an event, a
disease, or an outbreak of public health significance. On the national
level, these data are used to improve nationwide situational awareness
and enhance responsiveness to hazardous events and disease outbreaks to
protect America's health, safety, and security.
The BioSense Program was created by congressional mandate as part
of the Public Health Security and Bioterrorism Preparedness and
Response Act of 2002 and was launched by the CDC in 2003. The BioSense
Program has since been expanded into the National Syndromic
Surveillance Program (NSSP) which promotes and advances development of
a syndromic surveillance system for the timely exchange of syndromic
data.
CDC requests a three-year approval for a Revision for NSSP (OMB
Control No. 0920-0824, Expiration Date 5/31/2019). This Revision
includes a new request for approval to receive onboarding data from
state, local and territorial public health departments about healthcare
facilities in their jurisdiction.
NSSP features the BioSense Platform and a collaborative Community
of Practice. The BioSense Platform is a secure integrated electronic
health information system that CDC provides, primarily for use by
state, local and
[[Page 24153]]
territorial public health departments. It includes standardized
analytic tools and processes that enable users to rapidly collect,
evaluate, share, and store syndromic surveillance data. NSSP promotes a
Community of Practice in which participants collaborate to advance the
science and practice of syndromic surveillance. Health departments use
the BioSense Platform to receive healthcare data from facilities in
their jurisdiction, conduct syndromic surveillance, and share the data
with other jurisdictions and CDC.
The BioSense Platform provides the ability to analyze healthcare
encounter data from EHRs, as well as laboratory data. All EHR and
laboratory data reside outside of CDC in a cloud-enabled, web-based
platform that has Authorization to Operate from CDC. The BioSense
Platform sits in the secure, private Government Cloud which is simply
used as a storage and processing mechanism, as opposed to on-site
servers at CDC. This environment provides users with easily managed on-
demand access to a shared pool of configurable computing resources such
as networks, servers, software, tools, storage, and services, with
limited need for additional IT support. Each site (i.e., state or local
public health department) controls its data within the cloud and is
provided with free secure data storage space with tools for posting,
receiving, controlling and analyzing their data; an easy-to-use data
display dashboard; and a shared environment where users can collaborate
and advance public health surveillance practice. Each site is
responsible for creating its own data use agreements with the
facilities that are sending the data, retains ownership of any data it
contributes to its exclusive secure space, and can share data with CDC
or users from other sites.
NSSP has three different types of information collection:
(1) Collection of onboarding data about healthcare facilities
needed for state, local, and territorial public health departments to
submit EHR data to the BioSense Platform;
(2) Collection of registration data needed to allow users access to
the BioSense Platform tools and services; and
(3) Collection of data sharing permissions so that state and local
health departments can share data with other state and local health
departments and CDC.
Healthcare data shared with CDC can include: EHR data received by
state and local public health departments from facilities including
hospital emergency departments and inpatient settings, urgent care, and
ambulatory care; laboratory tests ordered and their results from
LabCorp, a national private sector laboratory company; and EHR data
from the Department of Defense (DoD) and the Department of Health and
Human Services (HHS) National Disaster Medical System (NDMS) Disaster
Medical Assistance Teams (DMATs).
Respondents include state, local, and territorial public health
departments. There are no costs to respondents other than their time to
participate. The only burden incurred by the health departments are for
submitting onboarding data about facilities to CDC, submitting
registration data about users to CDC, and setting up data sharing
permissions with CDC. The estimated annual burden is 195 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
State, Local, and Territorial Public Onboarding.............. 10 100 10/60
Health Departments.
State, Local, and Territorial Public Registration............ 10 15 10/60
Health Departments.
State, Local, and Territorial Public Data Sharing Permissions 10 1 15/60
Health Departments.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-10835 Filed 5-23-19; 8:45 am]
BILLING CODE 4163-18-P
